Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-15-009601
Filing Date
2015-12-21
Accepted
2015-12-21 08:14:55
Documents
1
Effectiveness Date
2015-12-21

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS defa14a122115a_relmada.htm DEFA14A 78039
  Complete submission text file 0001213900-15-009601.txt   79124
Mailing Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036
Business Address 546 FIFTH AVENUE, 14TH FLOOR NEW YORK NY 10036 212-702-7163
RELMADA THERAPEUTICS, INC. (Filer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 000-55347 | Film No.: 151298286
SIC: 2834 Pharmaceutical Preparations